tirzepatide psychiatric side effects Frontiers π New research in obesity
Description
Because our approach addresses the root causes of weight gainnot just the symptomsyoull gain the knowledge and tools to maintain your results and live a healthier, more balanced life
novel delivery If you cannot beat the pen, bypass it
In November 2024, COFEPRIS approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in Mexico
Serious side effects : have included pancreatitis, gallbladder disease, acute kidney injury, hypoglycemia, and severe allergic or injection-site reactions
Sharing needles or pens can result in transmission of infection
